Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Adds Inflammation Targets To Its 2020 R&D Collaboration With Arcus

May 15 2023

• By Joseph Haas

Expansion — Gilead and Arcus are expanding their ongoing R&D collaboration • Source: Shutterstock

Related Content

Gilead Opts In On Multiple Arcus IO Candidates, Setting Up Combo Therapy Plans

Nov 18 2021

Arcus And Gilead Keep TIGIT Dream Alive Despite Trial Shortcomings

Dec 21 2022

Gilead Partnership With Arcus Brings PD-1, TIGIT Assets To Its IO Portfolio

May 27 2020

Related Companies

Gilead Sciences, Inc.

Arcus Biosciences, Inc.

Additional Topics

Deals Business Strategies Commercial Inflammation BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.